Article
Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
PloS one - 1 Jan 2014
Noda Kazuki, Nakajima Sota, Godo Shigeo, Saito Hiroki, Ikeda Shohei, Shimizu Toru, Enkhjargal Budbazar, Fukumoto Yoshihiro, Tsukita Sohei, Yamada Tetsuya, Katagiri Hideki, Shimokawa Hiroaki
Abstract excerpt
BACKGROUND: Metabolic disorders, caused by excessive calorie intake and low physical activity, are important cardiovascular risk factors. Rho-kinase, an effector protein of the small GTP-binding protein RhoA, is an important cardiovascular therapeutic target and its activity is increased in patients with metabolic syndrome. We aimed to examine whether Rho-kinase inhibition improves high-fat diet (HFD)-induced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
